RaMBat : Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects
Molecular Oncology · 2026-04 · 20 (4) · 1074-1089
DOI: 10.1002/1878-0261.70211 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Oncology, online erschienen am 22.01.2026. Verfasst von Mengtao Sun und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, USA. Hauptthemen laut MEDLINE: Medulloblastoma, Cerebellar Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIGMS NIH HHS, U.S. National Science Foundation (NSF) Division of Information and Intelligent Systems (IIS).
Abstract (Originalsprache)
As the most common pediatric brain malignancy, medulloblastoma (MB) includes multiple distinct molecular subtypes characterized by clinical heterogeneity and genetic alterations. Accurate identification of MB subtypes is essential for downstream risk stratification and tailored therapeutic design. Existing MB subtyping approaches perform poorly due to limited cohorts and severe batch effects when integrating various MB data sources. To address these concerns, we propose a novel approach called RaMBat for accurate MB subtyping from diverse data sources with severe batch effects. Benchmarking tests based on 13 datasets with severe batch effects suggested that RaMBat achieved a median accuracy of 99%, significantly outperforming state‐of‐the‐art MB subtyping approaches and conventional machine learning classifiers. RaMBat could efficiently deal with the batch effects and clearly separate subtypes of MB samples from diverse data sources. We believe RaMBat will bring direct positive impacts on downstream MB risk stratification and tailored treatment design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, USA.
- Department of Neurological Sciences, University of Nebraska Medical Center, Omaha, USA.
- Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, USA.
ORCID-Profile: Mengtao Sun, Shibiao Wan
Förderung
- NIH HHS
- NIGMS NIH HHS
- U.S. National Science Foundation (NSF) Division of Information and Intelligent Systems (IIS)
- NCI NIH HHS
- American Cancer Society
- National Institute of General Medical Sciences
- National Science Foundation
- National Institutes of Health
Zitieren
APA
Sun, M., Wang, J., & Wan, S. (2026). RaMBat : Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects. Molecular Oncology, 20(4), 1074-1089. https://doi.org/10.1002/1878-0261.70211
Vancouver
Sun M, Wang J, Wan S. RaMBat : Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects. Molecular Oncology. 2026;20(4):1074-1089. doi:10.1002/1878-0261.70211
BibTeX
@article{Sun2026,
author = {Sun, Mengtao and Wang, Jieqiong and Wan, Shibiao},
title = {RaMBat : Accurate identification of medulloblastoma subtypes from diverse data sources with severe batch effects},
journal = {Molecular Oncology},
year = {2026},
volume = {20},
number = {4},
pages = {1074--1089},
doi = {10.1002/1878-0261.70211}
}
EUVIMED